During investigations of heterocycle condensed purines to obtain selective PDE4 inhibitors, we found that some heterocycle [i]-condensed purines inhibited PDE4 more effectively than did [a]-, [b]-, [c,d]-and [g,h]-condensed purines. 4)Among heterocycle [i]-condensed purines, 3,4-dipropyl-4,5,7,8-terahydro-3H-imidazo[2,1-i]purine-5-one (1) showed selective PDE4 inhibitory activity and lacked some of the adverse reactions of xanthine derivatives. 5) Additionally, 1 did not show emetic action, which is one in the development of PDE4 inhibitors. In the course of subsequent investigations, we found that tetrahydroimidazo[2,1-i]purines (dl-2a, dl-2d and dl-3a, dl-3d), with a methyl group at 7-or 8-position, although causing a decline in selectivity, affect the PDE4 inhibitory activities more strongly than does 1.
4)The present study was undertaken to determine whether there is a difference between the PDE4 inhibitory activities of (R)-and (S)-isomers of 8-alkyl-(2a-c, 3a-c) and those of 7-methyl-imidazo[2,1-i]purines (2d, 3d). We report here on the synthesis and PDE4 inhibitory activity of imidazo[2,1-i]purines.Chemistry Substituted imidazo[2,1-i]purines were prepared using the pathway we previously described. 4,5) Treatment of 3-propyl-6-(1,2,4-triazol-4-yl)purine (4) or 6-chloro-3-propylpurine (7) with each of the (R)-and (S)-isomers of 2-amino-1-propanol, 2-amino-1-butanol, 2-amino-3-methyl-1-butanol, and 1-amino-2-propanol yielded the corresponding 6-(hydroxyethylamino)purines (5a-d, 8a-d
BIOLOGICAL RESULTS AND DISCUSSIONThe inhibitory activities of the imidazo[2,1-i]purines (2a-d, 3a-d) against PDE1 and PDE4 isoenzymes from guinea-pig brain and PDE3 from guinea-pig heart were measured according to published methods.6) The results are shown in Table 1 We investigated the structure-activity relationship of the (R)-and (